Home Prognostic significance of smudge cell percentage in chronic lymphocytic leukemia. Facts or artifacts? Methodological considerations and literature review
Article
Licensed
Unlicensed Requires Authentication

Prognostic significance of smudge cell percentage in chronic lymphocytic leukemia. Facts or artifacts? Methodological considerations and literature review

  • Antonio La Gioia ORCID logo EMAIL logo , Paolo Chiarugi , Maurizio Fumi , Fabiana Fiorini , Celeste Giampietro ORCID logo , Enrico Michelucci , Franca Veroni , Marcello Fiorini ORCID logo , Francesca Aquila , Vincenzo Rocco and Giovanni Pellegrini
Published/Copyright: August 29, 2022

Received: 2022-07-08
Accepted: 2022-08-22
Published Online: 2022-08-29
Published in Print: 2022-10-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Measuring FGF23 in clinical practice: dream or reality?
  4. Reviews
  5. Fibroblast growth factor 23: translating analytical improvement into clinical effectiveness for tertiary prevention in chronic kidney disease
  6. Pursuing appropriateness of laboratory tests: a 15-year experience in an academic medical institution
  7. General Clinical Chemistry and Laboratory Medicine
  8. Moving average quality control of routine chemistry and hematology parameters – a toolbox for implementation
  9. Practical application of European biological variation combined with Westgard Sigma Rules in internal quality control
  10. Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia
  11. Early predictors of abnormal MRI patterns in asphyxiated infants: S100B protein urine levels
  12. Interlaboratory comparison study of immunosuppressant analysis using a fully automated LC-MS/MS system
  13. Analytical evaluation and bioclinical validation of new aldosterone and renin immunoassays
  14. Improving clinical performance of urine sediment analysis by implementation of intelligent verification criteria
  15. Clinical evaluation of the OC-Sensor Pledia calprotectin assay
  16. Serous body fluid evaluation using the new automated haematology analyser Mindray BC-6800Plus
  17. Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients
  18. Reference Values and Biological Variations
  19. Within-subject biological variation estimates using an indirect data mining strategy. Spanish multicenter pilot study (BiVaBiDa)
  20. Short-term biological variation of serum glial fibrillary acidic protein
  21. Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort
  22. Serum GFAP – reference interval and preanalytical properties in Danish adults
  23. Determination of pediatric reference limits for 10 commonly measured autoantibodies
  24. Hematology and Coagulation
  25. Arterial and venous blood sampling is equally applicable for coagulation and fibrinolysis analyses
  26. Infectious Diseases
  27. Free urinary sialic acid levels may be elevated in patients with pneumococcal sepsis
  28. Letters to the Editor
  29. Thyroid stimulating hormone: biased estimate of allowable bias
  30. Letter to the Editor relating to Clin Chem Lab Med 2022;60(9):1365–72
  31. Reply to the Letter of Sun et al. [1] relating to Clin Chem Lab Med 2022;60(9):1365–72
  32. Prognostic significance of smudge cell percentage in chronic lymphocytic leukemia. Facts or artifacts? Methodological considerations and literature review
  33. Detection of a monoclonal component after pediatric liver transplantation: a case report
  34. Reporting magnesium critical results: clinical impact on pregnant women and neonates
  35. Congress Abstracts
  36. 54th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0658/html
Scroll to top button